Navigation Links
CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
Date:11/26/2007

BRANFORD, Conn., Nov. 26 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), a clinical-stage biopharmaceutical company focused on oncology, and TopoTarget A/S (Copenhagen Stock Exchange: TOPO) announced today that updated preliminary clinical trial results from the Phase II study of belinostat for T-cell lymphomas, and new preclinical data evaluating belinostat on pediatric leukemia cell lines, will be presented at the 2007 American Society of Hematology (ASH) 49th Annual Meeting in Atlanta, GA, on Monday, December 10, 2007.

The presentation details are as follows:

Title: Belinostat (PXD101) in Patients with Recurrent or Refractory

Peripheral or Cutaneous T-Cell Lymphoma: Results of a Phase

II Study

Date/Time: Monday, December 10, 2007, 5:00 - 7:00 PM EST

Session: Lymphoma: Chemotherapy, excluding Pre-Clinical Models-

Diffuse Large Cell Lymphoma and T-Cell Lymphoma

Poster board: 672-II

Abstract: 3453

Title: Investigation of the Efficacy of PXD101 (Belinostat) on

Primary Leukaemic Cells and Cell Lines as a Novel Agent for

Childhood Acute Lymphoblastic Leukaemia (ALL)

Date/Time: Monday, December 10, 2007, 5:00 - 7:00 PM EST

Session: Acute Lymphocytic Leukemia: Biology and Pathophysiology

Poster board: 12-III

Abstract: 2793

These abstracts are currently available online at http://www.abstracts2view.com/hem07. Following their presentation on December 10, 2007, reprints of the posters will be made available on CuraGen's website at '/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... NYACK, N.Y. , July 2, 2015  Before you ... plan ahead so you can stay safe and healthy. Take ... plants #summersafety. Infographic http://nyackhospital.org/summersafety Protect Your ... rays from the sun can increase your risk of skin ... the shade as much as possible, especially during midday hours. ...
(Date:7/2/2015)... , July 2, 2015 Releases ... ,Friendly Aedes aegypti , , reduced the ... Brazil by 95%, well below the ... (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal PLOS Neglected ... of Oxitec,s genetically engineered mosquitoes. The results showed that ...
(Date:7/2/2015)... NEW YORK , July 2, 2015 /PRNewswire/ ... of a conspicuously high-growth market segment in hematology ... research publisher said that Roche,s recent unveiling of its ... into the cobas m 511 hematology ... not only capture growth enjoyed by current leader ...
Breaking Medicine Technology:First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3
... LLC , an established CRO providing clinical research services ... biotechnology industry, announced today that President and CEO David ... Clinical Research in Emerging Countries conference July 28-29 ... ) The paradigm of traditional drug development ...
... (NASDAQ: ELGX ), developer and marketer of innovative ... three and six months ended June 30, 2011. ... are pleased with our progress during the quarter and remain ... goals for 2011.  In the second quarter, global revenue grew ...
Cached Medicine Technology:ClinStar to Present on Conducting Clinical Trials in Russia 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 2Endologix Reports 22% Second Quarter 2011 Revenue Growth 3Endologix Reports 22% Second Quarter 2011 Revenue Growth 4Endologix Reports 22% Second Quarter 2011 Revenue Growth 5Endologix Reports 22% Second Quarter 2011 Revenue Growth 6Endologix Reports 22% Second Quarter 2011 Revenue Growth 7Endologix Reports 22% Second Quarter 2011 Revenue Growth 8Endologix Reports 22% Second Quarter 2011 Revenue Growth 9
(Date:7/2/2015)... , ... July 02, 2015 , ... “ LIFX ” ... latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert and ... bulbs are the most versatile smart light bulbs on the market. , According to ...
(Date:7/2/2015)... ... July 02, 2015 , ... As Americans celebrate the Fourth ... temps, skin cancer is on the rise. July is UV Safety Month, and physicians ... about the importance of getting skin checks. Experts say most skin cancers can be ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... of the SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have ... Their significant popularity has inspired four new, fun shades including: blue, lime, pink ...
(Date:7/2/2015)... CITY, GA (PRWEB) , ... July 02, 2015 , ... ... their newest innovation in compression socks designed for men. , For style that’s ... socks into their daily routine. This is great news for men everywhere because a ...
(Date:7/2/2015)... ... 2015 , ... Six months ahead of his 80th birthday, Don Stevenson has ... money for the Pulmonary Hypertension Association (PHA). Stevenson began the walk in Washington ... by mid-September. He left Glasgow, Mont. yesterday morning and is making his way to ...
Breaking Medicine News(10 mins):Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... March 25 "Today was a monumental day on ... and provide long-term services and supports.We commend the Senate ... and supports in this year,s health care reform. Long-term ... role in America,s health care crisis. The needs are ...
... mice reports a more powerful immune response than from an ... much nicer it would be to get vaccinated by drinking ... , That might someday be the case, thanks to ... probiotics, which are healthy bacteria found in dairy products such ...
... 25 AmeriCares, a nonprofit international relief organization, is ... of lifesaving medicines and medical supplies to its partner, ... The medical aid will help people in the ... diarrhea and chronic diseases, in addition to pre-natal vitamins ...
... for best health plans in the countryEAGAN, Minn., ... of Minnesota announced today that it has earned ... health plans by the National Committee on Quality ... a private 501(c)(3) non-profit organization dedicated to driving ...
... March 25 Persons who purchased or paid for (in ... other entities that reimbursed for (in whole or in part) ... be eligible for relief as part of a $28 million ... GlaxoSmithKline ("GSK") manufactured between April 1, 2002 and March 4, ...
... Friday 20 March, US researcher Dr. Chris Beecher from the ... an N-methyl derivative of the amino acid glycine, at the ... a colleague of lead author Dr. Arun Sreekumar. The research ... 1,000 small molecules in tissues associated with prostate cancer. These ...
Cached Medicine News:Health News:Statement From Larry Minnix, President & CEO of the American Association of Homes and Services for the Aging, on the Senate Finance Committee Hearing 'The Role of Long-term Care in Health Reform' and the Reintroduction of the CLASS Act 2Health News:Statement From Larry Minnix, President & CEO of the American Association of Homes and Services for the Aging, on the Senate Finance Committee Hearing 'The Role of Long-term Care in Health Reform' and the Reintroduction of the CLASS Act 3Health News:Oral Yogurt 'Vaccine' Could Blunt Ouch Factor 2Health News:AmeriCares and International Medical Corps Partner to Bring Lifesaving Aid to Chad 2Health News:Blue Cross Earns Highest National NCQA Accreditation Status for Quality Service and Care 2Health News:Proposed Settlement Will Make Up to $28 Million Available to Individuals Who Purchased and Companies That Reimbursed for Paxil CR(R) 2Health News:A new approach to prostate cancer detection 2
... Opmi Vario/NC33 system microscope provides surgeons ... pathology. These microscopes are ideal for many ... compact. Ergonomically designed at every point of ... utilized in a surgical microscope allows intuitive ...
DUALSWITCH-SHUNTSYSTEM for L-P-Derivation...
26 cm - 10 1/4, 140 mm - 5 1/2, bayonet-shaped, flexible, 90 angle, 4 mm...
Toothed pituitary rongeur....
Medicine Products: